


Ask a doctor about a prescription for DOXAZOSIN NEO VIATRIS 8 mg PROLONGED-RELEASE TABLETS
Package Leaflet: Information for the Patient
Doxazosin NEO Viatris 8 mg prolonged-release tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Your doctor may have prescribed Doxazosin NEO Viatris because you have high blood pressure and it may increase your risk of suffering from heart disease or stroke if left untreated. The active substance of the tablets, doxazosin, belongs to a group of medicines called alpha-1 blockers. These medicines work by widening the blood vessels, making it easier for the heart to pump the blood that circulates through them. This helps to lower high blood pressure and reduce the risk of heart disease.
Similarly, you may have been prescribed Doxazosin NEO Viatris to treat the symptoms of benign prostatic hyperplasia (BPH). This disease means that the prostate, which is located just below the bladder in men, is enlarged. This makes it difficult to empty the bladder. Doxazosin NEO Viatris works by relaxing the muscles around the bladder outlet and the prostate gland, making it easier to empty the bladder.
Doxazosin may also be authorized for the treatment of other conditions not listed in this leaflet. Ask your doctor, pharmacist, or other healthcare professional if you have any other questions and always follow their instructions.
Do not take Doxazosin NEO Viatris
Warnings and precautions
Consult your doctor or pharmacist before starting to take Doxazosin NEO Viatris
Before starting treatment with Doxazosin NEO Viatris, your doctor will perform tests to rule out the possibility that you have other conditions, such as prostate cancer, which can cause the same symptoms as benign prostatic hyperplasia.
During treatment
When you start taking Doxazosin NEO Viatris, you may feel dizzy, weak, or feel like you are going to lose consciousness when standing up after sitting or lying down. If you feel dizzy or like you are going to faint, sit or lie down until you feel better or avoid situations where you may fall or get hurt. Your doctor may want to check your blood pressure regularly when you start taking this medicine to reduce the possibility of these effects.
If you are going to undergo cataract surgery (clouding of the lens), you should inform your ophthalmologist that you are taking doxazosin or have taken it before. This is because doxazosin may cause complications during surgery that the specialist can treat if prepared in advance.
Very rarely, persistent and painful erections can occur. If this happens, you should contact your doctor immediately.
If you are going to have a urine or blood test, tell the doctor or nurse that you are taking Doxazosin NEO Viatris. This medicine may affect the results of some tests.
On occasion, you may notice something in your stool that looks like a tablet. This is normal. The active substance of the prolonged-release tablets is contained in a non-absorbable coating, which is specially designed to release the medicine slowly into the body. When the process is complete, the empty coating is eliminated from the body in the stool.
Consult your doctor or pharmacist if you have any doubts.
Children and adolescents
The use of Doxazosin NEO Viatris is not recommended in children or adolescents under 18 years of age, as its safety and efficacy have not been established.
Other medicines and Doxazosin NEO Viatris
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription. Inform your doctor especially if you are taking:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
This information only applies to patients who are taking Doxazosin NEO Viatris to treat high blood pressure.
Pregnancy
Do not take Doxazosin NEO Viatris without talking to your doctor first if you are pregnant or trying to become pregnant. The experience with the use of doxazosin during pregnancy is limited.
Breastfeeding
Do not take Doxazosin NEO Viatris if you are breastfeeding.
Alternatively, you should stop breastfeeding when treatment with doxazosin is necessary.
Driving and using machines
Doxazosin NEO Viatris may cause drowsiness. Be especially careful when taking the first dose, if your dose is increased, or if you start taking this medicine again after a period of time. If you feel dizzy or drowsy, do not drive or use machines.
It is your responsibility to evaluate whether you are fit to drive or perform tasks that require a high level of alertness. One of the factors that can affect your ability to do so is the use of medicines, due to their effects and/or side effects. These effects and side effects are described in other sections. Therefore, read all the information in this leaflet to guide you. Consult your doctor or pharmacist if you have any doubts.
Doxazosin NEO Viatris contains sodium
This medicine contains less than 1 mmol (23 mg) of sodium per tablet, so it is essentially "sodium-free".
Follow exactly the instructions of administration of this medicine given by your doctor. If you are in doubt, ask your doctor or pharmacist.
Treatment of high blood pressure and symptoms of benign prostatic hyperplasia:
Use in adults (including elderly patients)
The recommended dose of doxazosin is 4 mg of doxazosin per day, although your doctor may increase the dose up to a maximum of 8 mg of doxazosin (one tablet) per day.
The maximum recommended dose is 8 mg of doxazosin once daily. The optimal effect may take up to four weeks to achieve.
Use in patients with liver problems
Your doctor may reduce the dose or monitor you more closely. Do not take doxazosin if you have severe liver problems.
Taking the medicine
Doxazosin NEO Viatris has been formulated in a special way so that the release of the active substance is slow throughout the day. Choose a time of day that is convenient for you and always take the tablets at that time. The tablets should be swallowed whole with sufficient liquid, with or without food. They should not be chewed, broken, or crushed.
If you take more Doxazosin NEO Viatris than you should
If you ingest too many tablets or if, for example, a child takes the medicine by mistake, contact your doctor or the hospital emergency department immediately and lie down. You may experience headaches, dizziness, fainting, drowsiness, loss of consciousness, breathing difficulties, low blood pressure, palpitations, irregular or very fast heartbeat, nausea, vomiting, or low blood sugar or potassium levels.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount used.
If you forget to take Doxazosin NEO Viatris
If you forget to take a dose, do not worry. Simply take the next day's dose at the usual time. Do not take a double dose to make up for forgotten doses.
If you stop taking Doxazosin NEO Viatris
Continue taking the tablets until your doctor tells you to stop.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience any of the following side effects, stop taking this medicine and contact your doctor immediately or go to the emergency department of your nearest hospital:
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect up to 1 in 10,000 people)
Other possible side effects could be:
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Very rare(may affect up to 1 in 10,000 people)
Frequency not known(cannot be estimated from the available data)
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
You can also report side effects directly through the Spanish Medicines Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after CAD or EXP. The expiry date is the last day of the month shown.
This medicine doesnot require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Doxazosina NEO Viatris
The active ingredient is doxazosina. Each prolonged-release tablet contains 8 mg of doxazosina (as doxazosina mesylate).
The other components are:
Tablet core: polyethylene oxide, microcrystalline cellulose, povidone, butylhydroxytoluene, all-rac-α-tocopherol, anhydrous colloidal silica, sodium stearyl fumarate.
Tablet coating: methacrylic acid - ethyl acrylate copolymer, anhydrous colloidal silica, macrogol, titanium dioxide (E-171).
Product Appearance and Container Content
Doxazosina NEO Viatris tablets are white, round, biconvex, and engraved with "DH" on one side.
They are available in blister packs of 7, 10, 14, 15, 28, 30, 50 x 1, 56, 60, 98, and 100 tablets.
Only some pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Viatris Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Manufacturer
Mylan Hungary Kft.
H-2900 Komarom
Mylan utca 1
Hungary
McDermott Laboratories Limited T/A Gerard Laboratories
Unit 35/36 Baldoyle Industrial Estate
Grange Road, Dublin 13
Ireland
For further information about this medicinal product, please contact the local representative of the marketing authorization holder:
Viatris Pharmaceuticals, S.L.
C/ General Aranaz, 86
28027 - Madrid
Spain
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
Spain Doxazosina NEO Viatris 8 mg prolonged-release tablets EFG
France DOXAZOSINE MYLAN LP 8 mg, prolonged-release tablet
Netherlands Doxazosine Retard Mylan 8 mg, prolonged-release tablets
Portugal Doxazosina Mylan
Date of the last revision of this leaflet:January 2020
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) https://www.aemps.gob.es/
The average price of DOXAZOSIN NEO VIATRIS 8 mg PROLONGED-RELEASE TABLETS in November, 2025 is around 14.55 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for DOXAZOSIN NEO VIATRIS 8 mg PROLONGED-RELEASE TABLETS – subject to medical assessment and local rules.